Guidelines for reporting histopathology of cervical carcinoma



Similar documents
Invasive Cervical Cancer. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology

How To Compare The Effects Of A Hysterectomy And A Hysterectomy

SCAN Gynaecological Group. Clinical Management Protocols: Cancer of the Cervix.

Carcinoma of the Cervix. Kathleen M. Schmeler, MD Associate Professor Department of Gynecologic Oncology

SIGN. Management of cervical cancer. Scottish Intercollegiate Guidelines Network. A national clinical guideline

How to report Upper GI EMR/ESD specimens

Sentinel Lymph Node Mapping for Endometrial Cancer. Locke Uppendahl, MD Grand Rounds

Overview of Gynaecologic Cancer

Lung Carcinomas New 2015 WHO Classification. Spasenija Savic Pathology

Cervical Cancer. Cervical smear test. The cervix. Dysplasia. Cervical cancer. The female reproductive system

Understanding your pathology report

Pathology of lung cancer

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Surgical Staging of Endometrial Cancer

Cervical Cancer The Importance of Cervical Screening and Vaccination

PRIMARY TREATMENT CLINICAL PRESENTATION INITIAL EVALUATION. Conclude procedure with/without lymph node dissection

Explanation of your PAP smear

How To Treat A Uterine Sarcoma

PathoBasic - Vulva, Vagina, Cervix. E.Obermann

2015 RN.ORG, S.A., RN.ORG, LLC

Fact sheet 10. Borderline ovarian tumours. The difficult cases. What is borderline ovarian cancer (BOC)?

What is cervical cancer?

The Diagnosis of Cancer in the Pathology Laboratory

PROTOCOL OF THE RITA DATA QUALITY STUDY

Endometrial Cancer Treatment

YOUR LUNG CANCER PATHOLOGY REPORT

Protocol for an integrated data request of test results from the laboratories of pathological anatomy. SNOMED 3.5VF - users version January 2016

Chapter 14 Cancer of the Cervix Uteri

Cancer of the Exocrine Pancreas, Ampulla of Vater and Distal Common Bile Duct Proforma

Introduction: Tumor Swelling / new growth / mass. Two types of growth disorders: Non-Neoplastic. Secondary / adaptation due to other cause.

EIN. (Endometrial Intraepithelial Neoplasia): Improved Criteria for diagnosing endometrial precancer. Stanley J. Robboy, MD, FCAP,

CHAPTER 5. Tumours of the Uterine Cervix

Histopathology of Colorectal Cancer after Neoadjuvant Chemoradiation Therapy

Report series: General cancer information

Introduction to Gynecologic Oncology

Histopathology of Major Salivary Gland Neoplasms

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Cancer of the Cervix

Multiple Primary and Histology Coding Rules

Pathologic Assessment Of The Breast And Axilla After Preoperative Therapy

R-16: Chronic nonspecific cervisit

What is neuroendocrine cervical cancer?

Lip Cancer: Treatment & Reconstruction

THE RATIONALE FOR HYSTERECTOMY AFTER UTERINE CERVIX CONIZATION

Carcinoma of the vagina is a relatively uncommon disease, affecting only about 2,000 women in

Basic Professional Training Program for Associate Medical Technologist

Chapter 2 Staging of Breast Cancer

Lung Cancer. Ossama Tawfik, MD, PhD Professor, Vice Chairman Director of Anatomic &Surgical Pathology University of Kansas School of Medicine

Protocol for the Examination of Specimens From Patients With Carcinoma of the Endometrium

Diagnostic Challenge. Department of Pathology,

Immunohistochemical differentiation of metastatic tumours

Protocol for the Examination of Specimens From Patients With Tumors of the Peritoneum

Treatment Guidelines. Gynaecology SELCN. June 2012

Endometrial Cancer Histopathology Reporting Guide

Cervical Cancer Prevention and Early Detection What is cervical cancer?

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT

Metastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy

Primary -Benign - Malignant Secondary

Intraobserver and Interobserver Reproducibility of WHO and Gleason Histologic Grading Systems in Prostatic Adenocarcinomas

Policy Wording. Together, all the way.

General Information About Non-Small Cell Lung Cancer

Pap smears, cytology and CCHC lab work and follow up

Polyps. Hyperplasias. CAP 2011: Course AP104. The High Risk Benign Endometrium. Mutter and Nucci 1

TUMORS OF THE TESTICULAR ADNEXA and SPERMATIC CORD

Update on Mesothelioma

ATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA

Stomach (Gastric) Cancer. Prof. M K Mahajan ACDT & RC Bathinda

The society for lower genital tract disorders since 1964.

Ovarian mucinous lesions. Ovarian mucinous lesions: Common diagnostic dilemmas. Ovarian mucinous lesions: problematic issues

Carcinosarcoma of the Ovary

Best Clinical Practice

Cervical Cancer. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version NCCN.org. Continue

Cancer of the Cardia/GE Junction: Surgical Options

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium

EMR Can anyone do this?

Current Status and Perspectives of Radiation Therapy for Breast Cancer

How To Treat Cervical Cancer

Thymic carcinoma: update of current diagnostic criteria and histologic types

Understanding. Cervical Changes A Health Guide for Women. National Cancer Institute U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Endometrial cancer-carcinoma of the lining of the uterus-is the most common gynecologic

CARDCARE PROTECTOR CERTIFICATE OF INSURANCE

An abnormal Pap smear - what does it mean?

Surgical guidelines for the management of breast cancer

Male. Female. Death rates from lung cancer in USA

Cervical Cancer: Definitive Chemoradiation

INFLAMMATION AND REACTIVE CHANGES IN CERVICAL EPITHELIUM

HER2 Status: What is the Difference Between Breast and Gastric Cancer?

Transcription:

Guidelines for reporting histopathology of cervical carcinoma Naveena Singh, Consultant Pathologist

Introduction Cancer management is multidisciplinary Histopathology report has a MAJOR impact on management Main determinant of treatment and prognosis is STAGE Cervical cancer is clinically staged Preclinical cancers are entirely within the remit of the pathological report Parameters other than stage also influence management

Introduction Treatment options: Surgery Lymphadenectomy Radiotherapy Chemoradiation Sentinel node sampling Intensity-modulated RT Intrarterial NAC followed by surgery Choice of treatment Appropriate for stage Fertility LIMIT treatment complications 16 14 12 10 8 6 4 2 0 Symptomatic Screen detected

Treatment of cervical cancer Approaches FIGO Ia1 Cone biopsy (LLETZ) Simple hysterectomy FIGO Ia1 with LVSI Radical Hysterectomy/Radical trachelectomy with PLND FIGO Ia2: Radical Hysterectomy/Radical trachelectomy with PLND Brachytherapy +/- external beam pelvic radiation therapy American Cancer Society, 2012

Treatment of cervical cancer Approaches FIGO Ib1 Radical Hysterectomy/Radical trachelectomy with PLND and PALND; +/- adjuvant RT or chemort Brachytherapy +/- external beam pelvic radiation therapy FIGO Ib2 Radical chemoradiotherapy +/- surgery Radical Hysterectomy/Radical trachelectomy with PLND and PALND; +/- adjuvant RT or chemort if node +ve FIGO II+ Radical chemoradiotherapy American Cancer Society, 2012

Treatment of cervical cancer Change in approach in recent years Radical chemoradiotherapy is becoming the treatment of choice of all stages over Ia2 Surgery first choice in specific settings for fertility conservation (trachelectomy) As two stage procedure in node negative cases; no adverse prognostic features Radical hysterectomy has become a rare specimen!

Reporting specimens for cervical cancer Cancer specimens should be reported in standard format RCPath datasets list core macroscopic and microscopic items In cervix cancer these are different for excision and radical surgical specimens

90% by April 2014

Reporting specimens for cervical cancer: Excision specimens CORE MACROSCOPIC ITEMS: Type of specimen Measurements of each piece

Reporting specimens for cervical cancer: Excision specimens CORE MICROSCOPIC ITEMS Invasive malignancy: Type Differentiation/grade Distribution of invasive component: Unifocal/Multifocal Tumour size Maximum thickness/depth of invasion Presence of invasive foci present in 3/more sequential tissue slices of tissue

Reporting specimens for cervical cancer: Excision specimens Excision status: Incomplete/ Complete/Not assessable If complete excision, distance to closest resection margin in mm Specify margin: ectocervical/endocervical/deep radial Other features: Presence and grade of CIN/CGIN/SMILE Excision of intraepithelial neoplasia Lymphovascular space invasion

Reporting specimens for cervical cancer: Excision specimens Cone biopsy Pin out to fix Slice in neat parallel slices Embed all ONE SLICE PER CASSETTE!

Reporting specimens for cervical cancer: Excision specimens Cone biopsy, alternative method Slice proximal portion in neat parallel transverse slices Distal either radially or bread slices ONE SLICE PER CASSETTE!

Reporting specimens for cervical cancer: Excision specimens CORE MICROSCOPIC ITEMS Invasive malignancy: Type Differentiation/grade Distribution of invasive component: Unifocal/Multifocal Tumour size Maximum thickness/depth of invasion Presence of invasive foci present in 3/more sequential tissue slices of tissue Excision status: Incomplete/ Complete/Not assessable If complete excision, distance to closest resection margin in mm Specify margin: ectocervical/endocervical/deep radial Other features: Presence and grade of CIN/CGIN/SMILE Excision of intraepithelial neoplasia Lymphovascular space invasion

Reporting specimens for cervical cancer: Recognising stromal invasion Can be subtle Not all features seen in every case: Absence or loss of sharply-defined basement membrane Small, angulated buds of atypical squamous epithelial cells Arise from surface epithelium with CIN3, or from gland crypts Single or multiple Continuous with the dysplastic epithelium or detached. Hypermature appearance, typically with more abundant eosinophilic cytoplasm Nuclei are pleomorphic, may contain nucleoli or exhibit altered nuclear polarity. May show dyskeratosis

Reporting specimens for cervical cancer: Recognising stromal invasion Stromal reaction: inflammatory, oedematous, desmoplastic, rarely absent Loss of the orderly basal epithelial palisade in the atypical epithelial buds. Different patterns of stromal invasion: spray bud pattern, which comprises tiny nests of hypermature squamous cells confluent pattern invasive tongues Clinical outcome is strongly influenced by the depth of invasion but not by the pattern of invasion

Cyclin D1 Epithelial mesenchymal transition: Phenotypic and functional change in Ca cells Mesenchymal ch tics: loss of cohesiveness, stromal invasion, resistance to anoikis, intravasation, intravascular survival, low proliferation IHC: Loss of E-cadherin and beta-catenin Acquisition of vimentin Cyclin D1 expression

Reporting specimens for cervical cancer: Tumour type Squamous carcinoma Adenosquamous carcinoma Adenocarcinoma Neuroendocrine carcinoma Other, specify

Reporting specimens for cervical cancer: Tumour type WHO Classification: Squamous tumours and precursors Squamous carcinoma, not otherwise specified Keratinizing Non-keratinizing Basaloid Verrucous Warty Papillary Lymphoepithelioma-like Squamotransitional Early invasive (microinvasive) squamous cell carcinoma: THE USE OF THESE TERMS IS NOT RECOMMENDED Squamous intraepithelial neoplasia Poorly differentiated tumours Absent intercellular bridges and keratinisation, many mucin producing cells = adenoca p63 is useful to confirm squamous diffn Exclude Neuroendocrine ca

Reporting specimens for cervical cancer: Tumour type WHO classification: Glandular tumours and precursors Adenocarcinoma Mucinous adenocarcinoma Endocervical type Intestinal Signet-ring cell Minimal deviation Villoglandular Endometrioid adenocarcinoma Clear cell adenocarcinoma Serous adenocarcinoma Mesonephric adenocarcinoma Early invasive adenocarcinoma: NOT RECOMMENDED WITHOUT STAGE Adenocarcinoma in situ

Reporting specimens for cervical cancer: Tumour type WHO Classification: Other epithelial tumours Adenosquamous carcinoma Glassy cell carcinoma variant Adenoid cystic carcinoma Adenoid basal carcinoma Neuroendocrine tumours Carcinoid tumour Atypical carcinoid Small cell carcinoma Large cell neuroendocrine carcinoma Undifferentiated carcinoma

Reporting specimens for cervical cancer: Tumour differentiation/grade Well/Grade 1 Moderate/Grade 2 Poor/Grade 3 Not assessable/gx very early lesions N/A neuroendocrine carcinomas SCC: Controversial prognostic factor in cervical carcinoma Variety of grading systems Grading systems using multiple parameters show more consistent correlation with behaviour: Stendahl system or invasive front grading Modified Broders used most universally Base on keratinisation, cytonuclear atypia and mitotic activity AdenoCa: No agreed system, nuclear grade most appropriate

Reporting specimens for cervical cancer: Distribution of invasive component: Unifocal/Multifocal HPV has potential to produce field change More than one focus of neoplastic transformation may arise Multifocal stromal invasion can be detected in up to 12% of carcinomas Important not to overstage multiple FIGO stage IA1 or IA2 tumours as FIGO stage IB

Reporting specimens for cervical cancer: Distribution of invasive component: Unifocal/Multifocal Multifocal disease: foci separated by blocks of uninvolved cervical tissue (cut levels!) foci on separate cervical lips foci situated far apart from each other in the same section. Individual foci may be attached to, or discontinuous from, the epithelium Each focus of invasion is measured separately Staging based on dimensions of largest focus

Reporting specimens for cervical cancer: Distribution of invasive component: Unifocal/Multifocal Report should: state clearly that the tumour is multifocal provide dimensions of each of the separate foci indicate how the FIGO stage has been ascertained Such cases should to be referred to cancer centres for review, and should be discussed at the MDM

Reporting specimens for cervical cancer: Tumour dimensions Two dimensions are required for FIGO stage: depth and maximum width Depth of invasion: Taken from the base of the epithelium (surface or glandular) from which the carcinoma arises If no obvious epithelial origin, from the tumour base (the deepest focus of tumour invasion) to the base of the nearest surface epithelium

Reporting specimens for cervical cancer: Tumour depth

Reporting specimens for cervical cancer: Tumour width Horizontal spread/width/lateral extent of unifocal tumours; tumour present in less than 3 blocks: Use the section with the greatest tumour width Measure from one lateral edge of the tumour to the other Measurement of width is not limited to the confluent component of the tumour

Reporting specimens for cervical cancer: Tumour width

Reporting specimens for cervical cancer: Tumour width Width of unifocal tumours; tumour present in 3 or more blocks: may exceed 7 mm in its third dimension, i.e. the carcinoma may be more than FIGO stage IA2 third dimension determined by: block thickness x number of contiguous blocks showing invasion

Reporting specimens for cervical cancer: Other microscopic core items: Excision Excision status: assessable Incomplete/ Complete/Not If complete excision, distance to closest excision margin in mm Specify margin: ectocervical/endocervical/deep radial

Reporting specimens for cervical cancer: Tumour differentiation/grade Presence and grade of CIN/CGIN/SMILE Excision of intraepithelial neoplasia Lymphovascular space invasion

Reporting specimens for cervical cancer: Radical hysterectomy specimens: CORE MACROSCOPIC ITEMS Vaginal cuff: presence and dimensions Dimensions of uterus Adnexa: presence and normal/abnormal Tumour: Present or not Maximum dimensions of tumour (mm) Position Macroscopic involvement of vagina Macroscopic involvement of parametrial/paracervical tissues

Reporting specimens for cervical cancer: Radical hysterectomy

Reporting specimens for cervical cancer: Radical hysterectomy

Reporting specimens for cervical cancer: Radical hysterectomy: CORE MICROSCOPIC ITEMS Type Differentiation/grade Tumour size: Maximum horizontal dimension Thickness/depth of invasion Minimum thickness of uninvolved cervical stroma (minimum tumour-free rim) Position of minimum tumour-free rim Closest radial resection margin (include paracervical tissue) Position of closest radial resection margin Vaginal involvement Distance from distal vaginal margin, position Paracervical involvement Parametrial involvement Lymphovascular invasion CIN/CGIN/SMILE

Reporting specimens for cervical cancer: Radical hysterectomy Minimum thickness of uninvolved cervical stroma (minimum tumour-free rim) Position of minimum tumour-free rim Closest radial resection margin (include paracervical tissue) Position of closest radial resection margin Vaginal involvement Distance from distal vaginal margin, position Paracervical involvement Parametrial involvement

Slice proximal portion in neat parallel transverse slices Slice distal portion including vaginal cuff radially

Reporting specimens for cervical cancer: Radical trachelectomy uterus vagina

Reporting specimens for cervical cancer: Radical trachelectomy

Reporting specimens for cervical cancer: Radical trachelectomy

Reporting specimens for cervical cancer: Radical trachelectomy

Reporting specimens for cervical cancer: Radical trachelectomy

Reporting specimens for cervical cancer: Lymphadenectomy Pelvic nodes: (obturator, internal, external and common iliac nodes) Positive/Negative/Not sampled Left/Right: Total number of nodes Number of positive nodes Extranodal spread: Yes No Para-aortic nodes: Positive/Negative/Not sampled Total number of nodes Number of positive nodes Extranodal spread: Yes No

Reporting specimens for cervical cancer: Lymphadenectomy Sample each node group separately (or as received) LN >5mm can be bisected or sliced perpendicular to longest axis LN< 5mm embed whole One node per cassette as far as possible or indicate clearly how many are embedded

Reporting specimens for cervical cancer Thank you Questions?